Maldives vs Saint Lucia: Hepatitis B surface antigen (HBsAg) prevalence
Maldives
0.2%
in 2024
Saint Lucia
0.2%
in 2024
Maldives rank
82nd
Saint Lucia rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Maldives
- Saint Lucia
How they compare
Maldives currently reports 0.2% against 0.2% in Saint Lucia, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Maldives ahead.
Maldives ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Maldives | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.3% | 0.1% | Maldives |
| 2020s | 0.2% | 0.2% | 0.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Maldives or Saint Lucia?
- Maldives, at 0.2% against 0.2% in Saint Lucia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Maldives and Saint Lucia?
- 0.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and Saint Lucia?
- 10 years are reported by both, from 2015 to 2024.
- How do Maldives and Saint Lucia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Maldives ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.